DNA Aptamer Beacon Probe (ABP) for Monitoring of Adenosine Triphosphate Level in SW480 Cancer Cells Treated with Glycolysis Inhibitor 2-Deoxyglucose
Open Access
- 26 May 2023
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (11) , 9295
Abstract
Early cancer screening enables timely detection of carcinogenesis, and aids in prompt clinical intervention. Herein, we report on the development of a simple, sensitive, and rapid fluorometric assay based on the aptamer probe (aptamer beacon probe, ABP) for monitoring the energy-demand biomarker adenosine triphosphate (ATP), an essential energy source that is released into the tumor microenvironment. Its level plays a significant role in risk assessment of malignancies. The operation of the ABP for ATP was examined using solutions of ATP and other nucleotides (UTP, GTP, CTP), followed by monitoring of ATP production in SW480 cancer cells. Then, the effect of a glycolysis inhibitor, 2-deoxyglucose (2-DG), on SW480 cells was investigated. The stability of predominant ABP conformations in the temperature range of 23–91 °C and the effects of temperature on ABP interactions with ATP, UTP, GTP, and CTP were evaluated based on quenching efficiencies (QE) and Stern-Volmer constants (KSV). The optimized temperature for best selectivity of ABP toward ATP was 40 °C (KSV = 1093 M−1, QE = 42%). We have found that the inhibition of glycolysis in SW480 cancer cells by 2-deoxyglucose resulted in lowering of ATP production by 31.7%. Therefore, monitoring and modulation of ATP concentration may aid in future cancer treatment.Keywords
Funding Information
- National Science Centre, Poland (2020/37/N/ST4/02567)
This publication has 61 references indexed in Scilit:
- Targeting cellular metabolism to improve cancer therapeuticsCell Death & Disease, 2013
- Intracellular ATP Levels Are a Pivotal Determinant of Chemoresistance in Colon Cancer CellsCancer Research, 2012
- The combination of tephrosin with 2-deoxy-D-glucose enhances the cytotoxicity via accelerating ATP depletion and blunting autophagy in human cancer cellsCancer Biology & Therapy, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Targeting Cancer Cell Metabolism: The Combination of Metformin and 2-Deoxyglucose Induces p53-Dependent Apoptosis in Prostate Cancer CellsCancer Research, 2010
- Selection of aptamers for a protein target in cell lysate and their application to protein purificationNucleic Acids Research, 2009
- Fluorescent detection of ATP based on signaling DNA aptamer attached silica nanoparticlesNanotechnology, 2008
- Enhanced antitumor activity of an adriamycin + 5-fluorouracil combination when preceded by biochemical modulationAnti-Cancer Drugs, 1996
- A DNA Aptamer That Binds Adenosine and ATPBiochemistry, 1995
- Biochemical Modulation of Tumor Cell Energy in Vivo: II. A Lower Dose of Adriamycin is Required and a Greater Antitumor Activity is Induced when Cellular Energy is DepressedCancer Investigation, 1994